Literature DB >> 11251526

Low frequency of microsatellite instability in hereditary prostate cancer.

A K Ahman1, B A Jonsson, J E Damber, A Bergh, H Grönberg.   

Abstract

OBJECTIVE: To investigate whether there is widespread microsatellite instability (MSI) in families with hereditary prostate cancer (HPC). PATIENTS AND METHODS: Eighty-four prostate tumours from 80 Swedish men in 35 families with HPC were screened for genetic instability at microsatellite marker loci BAT-25, BAT-26, BAT-34C4, D2S123 and D17S250.
RESULTS: MSI was detected in only five individuals from different families. Three tumours (4%) were unstable at more than two MSI loci and hence classified as high-frequency MSI (MSI-H) according to a previous definition. Interestingly, two of the MSI-H tumours were from patients in families with both HPC and familial colon cancer.
CONCLUSIONS: Widespread MSI is a rare event in hereditary prostate cancer, indicating that defective DNA mismatch repair is not an important element in the genesis of HPC.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11251526     DOI: 10.1046/j.1464-410x.2001.00104.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  7 in total

1.  Hereditary prostate cancer as a feature of Lynch syndrome.

Authors:  Christina M Bauer; Anna M Ray; Bronwen A Halstead-Nussloch; Robert G Dekker; Victoria M Raymond; Stephen B Gruber; Kathleen A Cooney
Journal:  Fam Cancer       Date:  2011-03       Impact factor: 2.375

2.  Elevated microsatellite alterations at selected tetranucleotides (EMAST) and mismatch repair gene expression in prostate cancer.

Authors:  Maximilian Burger; Stefan Denzinger; Christine G Hammerschmied; Andrea Tannapfel; Ellen C Obermann; Wolf F Wieland; Arndt Hartmann; Robert Stoehr
Journal:  J Mol Med (Berl)       Date:  2006-08-03       Impact factor: 4.599

3.  Elevated risk of prostate cancer among men with Lynch syndrome.

Authors:  Victoria M Raymond; Bhramar Mukherjee; Fei Wang; Shu-Chen Huang; Elena M Stoffel; Fay Kastrinos; Sapna Syngal; Kathleen A Cooney; Stephen B Gruber
Journal:  J Clin Oncol       Date:  2013-03-25       Impact factor: 44.544

4.  Population-based study of the association of variants in mismatch repair genes with prostate cancer risk and outcomes.

Authors:  Wendy J Langeberg; Erika M Kwon; Joseph S Koopmeiners; Elaine A Ostrander; Janet L Stanford
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-01       Impact factor: 4.254

Review 5.  The convergence of DNA damage checkpoint pathways and androgen receptor signaling in prostate cancer.

Authors:  Huy Q Ta; Daniel Gioeli
Journal:  Endocr Relat Cancer       Date:  2014-08-05       Impact factor: 5.678

6.  Frequent mismatch-repair defects link prostate cancer to Lynch syndrome.

Authors:  Mev Dominguez-Valentin; Patrick Joost; Christina Therkildsen; Mats Jonsson; Eva Rambech; Mef Nilbert
Journal:  BMC Urol       Date:  2016-03-24       Impact factor: 2.264

7.  Prostate cancer incidence in males with Lynch syndrome.

Authors:  Sigurdis Haraldsdottir; Heather Hampel; Lai Wei; Christina Wu; Wendy Frankel; Tanios Bekaii-Saab; Albert de la Chapelle; Richard M Goldberg
Journal:  Genet Med       Date:  2014-01-16       Impact factor: 8.822

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.